Healthline

All About Prolia’s Dosage

If you have osteoporosis or have a risk for bone loss, your doctor might suggest Prolia (denosumab) as a treatment option for you. Prolia is a prescription medication that treats osteoporosis and ...
FierceBiotech

Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alend

New 2-Year Open-Label Study Shows More Than 90 Percent of Patients Preferred Prolia Injection Every Six Months Over Weekly Oral Alendronate THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen ...
Business Insider

European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis

Prolia is administered as a single subcutaneous injection of 60 mg once every six months. Please see the Important Safety Information below. EU Important EU Product Information Calcium and Vitamin D ...
FierceBiotech

FDA Approves New Indication For Prolia® (Denosumab) For The Treatment Of Bone Loss In Men With Osteoporosis At High Risk For Fracture

THOUSAND OAKS, Calif., Sept. 20, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia ® (denosumab) as a treatment ...
Insurancenewsnet.com

New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis

Prolia is administered as a single subcutaneous injection of 60 mg once every six months. Please see the Important Safety Information below. Important Safety Information (U.S.) Prolia is ...
Business Insider

Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis

Prolia is administered as a single subcutaneous injection of 60 mg once every six months. Please see the Important Safety Information below. EU Important EU Product Information Calcium and Vitamin D ...